Home Title

Transforming lives by breaking new ground in immunology treatment through specialist expertise

Transforming lives by breaking new ground in immunology treatment through specialist expertise

Transforming lives by breaking new ground in immunology treatment through specialist expertise.

Information on our 2023 AGM

AGM information
£59.6m Revenue (2022: £72.8m)
£(14.8)m Operating loss excluding R&D and exceptionals (2022: £3.4m operating profit excluding R&D)
£(43.1)m Net loss after tax (2022: £(13.8)m net loss after tax)

Our year in numbers

Annual Report 2023

Take your career to new heights

Career Vacancies